Related Experiment Video
Updated: Jul 8, 2025

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Subtyping irritable bowel syndrome using cluster analysis: a systematic review.
Diana Zarei1,2, Amene Saghazadeh3,4, Nima Rezaei5,6,7
1School of Medicine, Iran University of Medical Science, Tehran, Iran.
Cluster analysis reveals distinct subgroups within Irritable Bowel Syndrome (IBS) patients, highlighting variations in clinical presentation and biological markers. Methodological differences impact subgroup identification, necessitating further research for personalized IBS treatments.
Area of Science:
- Gastroenterology
- Computational Biology
- Biostatistics
Background:
- Irritable Bowel Syndrome (IBS) is a prevalent functional gastrointestinal disorder with diverse clinical manifestations.
- Cluster Analysis (CA) is a statistical method used to identify homogeneous subgroups within patient populations.
- Understanding IBS heterogeneity is crucial for developing targeted therapeutic strategies.
Approach:
- A literature review identified studies applying CA to Irritable Bowel Syndrome (IBS) patients.
- Searched major databases (PubMed, Embase, Web of Science, Scopus) for relevant articles.
- Analyzed studies based on variables, participant characteristics, methodology, and findings.
Key Points:
- K-means CA was the most common method (8 studies), followed by Hierarchical CA (4 studies) and Latent Class Analysis (2 studies).
- Studies focused on clinical symptoms (7), anocolorectal functions (4), immunology (2), and microbial composition (1).
- Subgroups showed variations in symptom severity, psychological findings, rectal sensitivity, colonic transit, and microbial profiles.
Conclusions:
- Cluster analysis identifies distinct IBS subgroups based on clinical, functional, and biological factors.
- Methodological heterogeneity in CA application leads to inconsistent subgroup identification.
- Further research is needed to refine CA methodologies for personalized IBS management.
More Related Videos
06:04Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling
Published on: January 17, 2025
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS